APrf Sunita De Sousa
Grant-Funded Researcher D
School of Medicine
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
A/Prof Sunita De Sousa is a Staff Specialist in Endocrinology and Genetics at the Royal Adelaide Hospital, and a Clinical Associate Professor at the University of Adelaide. She has completed an MSc at the University of London, and fellowships in pituitary endocrinology at St Vincent’s Hospital Sydney and clinical genetics in the SA Clinical Genetics Service. Her PhD on the genetics and clinical aspects of prolactinomas was awarded the 2020 University of Adelaide Doctoral Research Medal. With ongoing research funding from the Medical Research Future Fund (MRFF), Royal Australasian College of Physicians, Endocrine Society of Australia and Royal Adelaide Hospital, Sunita’s postdoctoral studies focus on monogenic diabetes and hereditary pancreatitis. Her recent research also covers pituitary tumours, paragangliomas, hyperparathyroidism and congenital adrenal hyperplasia. Sunita was most recently elected to the Council of the Endocrine Society of Australia. She also serves on the eviQ Cancer Genetics Reference Committee and the US Endocrine Society Steering Committee for Endocrine Cancers Special Interest Group, and she was a co-author of the recent Australian hyperparathyroidism guidelines. With the aid of local and interstate collaborators, Sunita is the founding member of EndoGen, a national network of endocrine genetic centres which has led to Australia’s first national endocrine genetics MDT meeting.
Sunita has two research streams: endocrine genetics and pituitary endocrinology. At the juncture of these subspecialties, she is highly active in the area of pituitary tumour genetics with ongoing basic and clinical international collaborations exploring putative new pituitary tumorigenesis genes including the CHEK2 gene. In endocrine genetics, her research also focuses on monogenic diabetes, hereditary pancreatitis and multiple endocrine neoplasia. Other topics in her pituitary endocrinology research include novel methodologies in both the assessment and treatment of pituitary tumours. Recent new appointments include Associate Editor, Editorial Board of Endocrine Oncology.
| Date | Position | Institution name |
|---|---|---|
| 2021 - ongoing | Clinical Associate Professor | University of Adelaide |
| 2019 - ongoing | Staff Specialist | Endocrine & Metabolic Unit, Royal Adelaide Hospital |
| 2018 - ongoing | Staff Specialist | South Australian Adult Genetics Unit, Royal Adelaide Hospital |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2020 | Award | University Doctoral Research Medal | University of Adelaide | Australia | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2020 | University of Adelaide | Australia | PhD |
| 2016 | Royal Australasian College of Physicians | Australia | FRACP |
| 2015 | University of London | United Kingdom | MSc |
| 2009 | University of New South Wales | Australia | MBBS (Hons) |
| Year | Citation |
|---|---|
| 2025 | Willemsen, A. L., Torpy, D. J., De Sousa, S., Falhammar, H., & Rushworth, R. L. (2025). 17α-hydroxylase/17,20-lyase deficiency (17-OHD): A Meta-analysis of Reported Cases.. The Journal of clinical endocrinology and metabolism, 110(4), e1261-e1271. Scopus1 WoS1 Europe PMC1 |
| 2025 | Mignone, E., Jukes, A. K., Valentine, R., Allison, R., & De Sousa, S. M. C. (2025). Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas.. Endocrine oncology (Bristol, England), 5(1), e240065. |
| 2025 | De Sousa, S. M. C., Phan, J. M. N., Wells, A., Wu, K. H. C., & Scott, H. S. (2025). Improving detection of monogenic diabetes through reanalysis of <i>GCK</i> variants of uncertain significance. ACTA DIABETOLOGICA, online(8), 7 pages. Scopus1 WoS3 Europe PMC1 |
| 2025 | Candy, N. G., Mignone, E., Quick, E., Koszyca, B., Brown, A., Chapman, I. M., . . . De Sousa, S. M. C. (2025). The role of BRAF testing of Rathke's cleft cysts to identify missed papillary craniopharyngioma.. Pituitary, 28(1), 30. Scopus2 WoS2 Europe PMC1 |
| 2025 | De Sousa, S. M. C., Phan, J. M. N., Wells, A., Wu, K. H. C., & Scott, H. S. (2025). Correction to: Improving detection of monogenic diabetes through reanalysis of GCK variants of uncertain significance (Acta Diabetologica, (2025), 10.1007/s00592-025-02449-8). Acta Diabetologica, 62(10), 1827-1828. |
| 2025 | Orsmond, A., Krishnan, G., Palmer, L. J., De Sousa, S. M. C., & McCormack, A. (2025). FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours.. Pituitary, 28(2), 39. Scopus2 WoS2 Europe PMC1 |
| 2025 | De Sousa, S. M. C. (2025). From bench to bedside in the sella: translational developments in pituitary tumour genetics. Endocrine Related Cancer, 32(5), 14 pages. |
| 2025 | Lim, W. T., Nenke, M., Rawlings, L., Wells, A., Vakulin, C., Waters, W., & De Sousa, S. (2025). A Mosaic PHEX Variant in Hypophosphatemic Rickets: Distinguishing Postzygotic Mutation from Sex Chromosome Aneuploidy. Calcified Tissue International, 116(1), 87. |
| 2025 | Orsmond, A., De Sousa, S. M. C., & McCormack, A. (2025). The landscape of germline variants in breast and colorectal cancer susceptibility genes in patients with pituitary tumours. Journal of Neuro Oncology, 175(1), 379-388. |
| 2025 | De Sousa, S. M., Davis, T. M., Harraway, J., Greenslade, M., Wu, K. H., Paul, R. G., . . . Greenfield, J. R. (2025). Australian and New Zealand joint society consensus statement on genetic testing for monogenic diabetes in adults.. The Medical journal of Australia, 223(9), 484-491. Scopus3 WoS2 Europe PMC3 |
| 2025 | Hilditch, C., Curtis, S., Cotton, S., LeBlanc, S., & De Sousa, S. (2025). Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism. Pituitary, 28(4), 5 pages. |
| 2025 | Valetopoulou, A., Newall, N., Khan, D. Z., Borg, A., Bouloux, P. M. G., Bremner, F., . . . McLean, A. L. (2025). A core outcome set for pituitary surgery research: an international delphi consensus study. Pituitary, 28(4), 88. Scopus2 Europe PMC2 |
| 2025 | Ovenden, C. D., Candy, N., McNeil, J., Dolovac, R. B., Castle-Kirszbaum, M., Helal, A., . . . Psaltis, A. (2025). Systematic review of fluorescence-guided surgery in pituitary neuroendocrine tumours.. Endocrine oncology (Bristol, England), 5(1), e250037. |
| 2025 | Ovenden, C., Mignone, E., Chapman, I., Torpy, D. J., Rankin, W., Jukes, A., . . . De Sousa, S. M. C. (2025). Early postoperative decline in insulin-like growth factor 1 (IGF-1) predicts surgical remission of acromegaly.. World neurosurgery, 205, 124611. |
| 2025 | Kusay, Y., Wu, D., De Sousa, S. M. C., Drogemuller, C. J., Coates, P. T., Kok, C. H., & Scott, H. S. (2025). Evaluating NGS variant callers in a challenging genomic context with a focus on the PRSS1-PRSS2 locus for hereditary pancreatitis. Gut, online, 1-3. |
| 2024 | De Sousa, S. M. C., Jukes, A. K., Candy, N. G., Chapman, I. M., Torpy, D. J., Shivalingam, B., . . . Santoreneos, S. (2024). Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern.. Nat Rev Endocrinol, 20(5), 314. Scopus6 WoS6 Europe PMC4 |
| 2024 | De Sousa, S. M. C., McCormack, A., Orsmond, A., Shen, A., Yates, C. J., Clifton Bligh, R., . . . Scott, H. S. (2024). Increased prevalence of germline pathogenic CHEK2 variants in individuals with pituitary adenomas. Journal Of Clinical Endocrinology & Metabolism, 109(11), 2720-2728. Scopus5 WoS5 Europe PMC7 |
| 2023 | Hayes, A. G., Shirazi, M. G., Thiyagarajah, A., Torpy, D. J., & De Sousa, S. M. C. (2023). Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma. Endocrine Oncology, 3(1), e220086. |
| 2023 | De Sousa, S. M. C., Lenders, N. F., Lamb, L. S., Inder, W. J., & McCormack, A. (2023). Pituitary tumours: molecular and genetic aspects. Journal of Endocrinology, 257(3), 16 pages. Scopus14 WoS12 Europe PMC10 |
| 2023 | De Sousa, S. M. C., Wu, K. H. C., Colclough, K., Rawlings, L., Dubowsky, A., Monnik, M., . . . Torpy, D. J. (2023). Identification of monogenic diabetes in an Australian cohort using the Exeter maturity-onset diabetes of the young (MODY) probability calculator and next-generation sequencing gene panel testing. Acta Diabetologica: an international journal devoted to the study of clinical and experimental diabetes and metabolism, 61(2), 181-188. Scopus3 WoS4 Europe PMC4 |
| 2023 | De Sousa, S. M. C., Shen, A., Yates, C. J., Clifton Bligh, R., Santoreneos, S., King, J., . . . Scott, H. S. (2023). PAM variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas. Frontiers In Endocrinology, 14(1305606), 1-10. WoS7 Europe PMC5 |
| 2022 | De Sousa, S. M. C., Carroll, R. W., Henderson, A., Burgess, J., & Clifton-Bligh, R. J. (2022). A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes. Endocrine, 75(1), 23-32. Scopus13 WoS13 Europe PMC12 |
| 2022 | Wu, D., Bampton, T. J., Scott, H. S., Brown, A., Kassahn, K., Drogemuller, C., . . . Coates, P. T. (2022). The clinical and genetic features of hereditary pancreatitis in South Australia.. Medical Journal of Australia, 216(11), 578-582. Scopus7 WoS5 Europe PMC4 |
| 2022 | De Sousa, S. M. C. (2022). Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?. Endocrine oncology (Bristol, England), 2(1), R31-R50. Europe PMC19 |
| 2021 | Miller, J. A., Gundara, J., Harper, S., Herath, M., Ramchand, S. K., Farrell, S., . . . Grossmann, M. (2021). Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society. Clinical Endocrinology, 101(5), 516-530. Scopus7 WoS6 Europe PMC6 |
| 2021 | Milat, F., Ramchand, S. K., Herath, M., Gundara, J., Harper, S., Farrell, S., . . . Grossmann, M. (2021). Primary hyperparathyroidism in adults—(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society. Clinical Endocrinology, 100(1), 3-18. Scopus7 WoS7 Europe PMC9 |
| 2021 | Meyer, E. J., Spangenberg, L., Ramírez, M. J., De Sousa, S. M. C., Raggio, V., & Torpy, D. J. (2021). CBG Montevideo: A Clinically Novel SERPINA6 Mutation Leading to Haploinsufficiency of Corticosteroid-binding Globulin. Journal of the Endocrine Society, 5(9), 8 pages. Scopus9 WoS8 Europe PMC6 |
| 2020 | De Sousa, S. M. C., Toubia, J., Hardy, T. S. E., Feng, J., Wang, P., Schreiber, A. W., . . . Torpy, D. J. (2020). Aberrant Splicing of SDHC in Families With Unexplained Succinate Dehydrogenase-Deficient Paragangliomas. Journal of the Endocrine Society, 4(12), 1-12. Scopus12 WoS12 Europe PMC12 |
| 2020 | De Sousa, S. M. C., Manavis, J., Feng, J., Wang, P., Schreiber, A. W., Scott, H. S., & Torpy, D. J. (2020). A putative role for the aryl hydrocarbon receptor (AHR) gene in a patient with cyclical Cushing's disease. BMC Endocrine Disorders, 20(article no. 18), 2-6. Scopus6 WoS6 Europe PMC5 |
| 2020 | De Sousa, S. M. C., Baranoff, J., Rushworth, R. L., Butler, J., Sorbello, J., Vorster, J., . . . Torpy, D. J. (2020). Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors.. The Journal of clinical endocrinology and metabolism, 105(3), 108-118. Scopus60 WoS47 Europe PMC41 |
| 2019 | McCabe, M. J., Gauthier, M. E. A., Chan, C. L., Thompson, T. J., De Sousa, S. M. C., & Cowley, M. J. (2019). Development and validation of a targeted gene sequencing panel for application to disparate cancers. Scientific Reports, 9(1), 1-16. Scopus23 WoS23 Europe PMC22 |
| 2019 | Du, Y. T., Moore, L., Poplawski, N. K., & De Sousa, S. M. C. (2019). Familial GATA6 mutation causing variably expressed diabetes mellitus and cardiac and renal abnormalities. Endocrinology, diabetes and metabolism case reports, 2019(1), 1-6. Scopus9 WoS2 Europe PMC6 |
| 2019 | De Sousa, S. M. C., Saleem, M., Rankin, W., & Torpy, D. J. (2019). Serum prolactin overestimation and risk of misdiagnosis. ENDOCRINOLOGY DIABETES & METABOLISM, 2(3), 4 pages. WoS4 Europe PMC4 |
| 2019 | De Sousa, S. M. C., Wang, P. P. S., Santoreneos, S., Shen, A., Yates, C. J., Babic, M., . . . Scott, H. S. (2019). The genomic landscape of sporadic prolactinomas. Endocrine pathology, 30(4), 318-328. Scopus18 WoS18 Europe PMC19 |
| 2019 | De Sousa, S. M. C., & Jesudason, D. (2019). Cover Image, Volume 90, Issue 1. Clinical Endocrinology, 90(1). |
| 2019 | De Sousa, S. M. C., & Jesudason, D. (2019). Rebound vertebral and non-vertebral fractures during denosumab interruption in a postmenopausal woman. Clinical Endocrinology, 90(1), 250-252. Scopus5 WoS4 Europe PMC3 |
| 2018 | De Sousa, S. M. C., Hardy, T. S. E., Scott, H. S., & Torpy, D. J. (2018). Genetic testing in endocrinology. Clinical Biochemist Reviews, 39(1), 17-28. Scopus16 Europe PMC9 |
| 2018 | De Sousa, S., Sheriff, N., Tran, C., Menzies, A., Tsang, V., Long, G., & Tonks, K. (2018). Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis. Pituitary, 21(3), 274-282. Scopus29 WoS25 Europe PMC20 |
| 2017 | De Sousa, S. M. C., McCormack, A. I., McGrath, S., & Torpy, D. J. (2017). Prolactin correction for adequacy of petrosal sinus cannulation may diminish diagnostic accuracy in Cushing's disease. Clinical Endocrinology, 87(5), 515-522. Scopus24 WoS23 Europe PMC14 |
| 2017 | De Sousa, S. M. C., Meyer, E. J., Rankin, W., Brautigan, P. J., Burt, M. G., & Torpy, D. J. (2017). Vasculogenic hyperprolactinemia: severe prolactin excess in association with internal carotid artery aneurysms. Pituitary, 20(6), 676-682. Scopus5 WoS4 Europe PMC4 |
| 2017 | De Sousa, S. M. C., Stowasser, M., Feng, J., Schreiber, A. W., Wang, P., Hahn, C. N., . . . Gagliardi, L. (2017). ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II). Journal of human hypertension, 31(12), 857-859. Scopus6 WoS3 Europe PMC5 |
| 2017 | De Sousa, S., Chapman, I., Falhammar, H., & Torpy, D. (2017). Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine, 55(2), 618-624. Scopus44 WoS37 Europe PMC31 |
| 2017 | De Sousa, S., McCabe, M., Wu, K., Roscioli, T., Gayevskiy, V., Brook, K., . . . McCormack, A. (2017). Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours. European Journal of Endocrinology, 176(5), 635-644. Scopus36 WoS29 Europe PMC27 |
| 2016 | De Sousa, S., Haghighi, K., Qiu, M., Greenfield, J., & Chen, D. (2016). Synchronous Nesidioblastosis, Endocrine Microadenoma, and Intraductal Papillary Mucinous Neoplasia in a Man Presenting with Hyperinsulinemic Hypoglycemia. Pancreas, 45(1), 154-159. Scopus10 WoS10 Europe PMC11 |
| 2016 | De Sousa, S. M. C., Kassahn, K. S., McIntyre, L. C., Chong, C. E., Scott, H. S., & Torpy, D. J. (2016). Case report of whole genome sequencing in the XY female: identification of a novel SRY mutation and revision of a misdiagnosis of androgen insensitivity syndrome. BMC Endocrine Disorders, 16(1), 58-1-58-7. Scopus7 WoS4 Europe PMC4 |
| 2016 | de Sousa, S. M. C., & Mccormack, A. I. (2016). Cutaneous lichen amyloidosis in multiple endocrine neoplasia. Internal Medicine Journal, 46(1), 116-117. Scopus3 WoS2 Europe PMC3 |
| 2016 | De Sousa, S., & Norman, R. (2016). Metabolic syndrome, diet and exercise. Best Practice and Research: Clinical Obstetrics and Gynaecology, 37, 140-151. Scopus48 WoS40 Europe PMC39 |
| 2016 | De Sousa, S. M. C., Maiti, K., Smith, R., & McCormack, A. I. (2016). Corticotrophin-releasing hormone (CRH) expression in the dermoid component of ovarian teratomas. Journal of the European Academy of Dermatology and Venereology, 30(5), 867-869. |
| 2015 | De Sousa, S. M. C., Earls, P., & McCormack, A. I. (2015). Pituitary hyperplasia: case series and literature review of an under-recognised and heterogeneous condition. ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2015, 7 pages. WoS19 Europe PMC24 |
| 2015 | Lam, T., Chan, M. M. K., Sweeting, A. N., De Sousa, S. M. C., Clements, A., Carlino, M. S., . . . Chipps, D. R. (2015). Ipilimumab-induced hypophysitis in melanoma patients: An Australian case series. Internal Medicine Journal, 45(10), 1066-1073. Scopus28 WoS25 Europe PMC21 |
| 2014 | De Sousa, S. M. C., Long, G. V., & Tonks, K. T. (2014). Ipilimumab-induced hypophysitis: Early Australian experience. Medical Journal of Australia, 201(4), 198-199. Scopus7 WoS7 Europe PMC7 |
| Year | Citation |
|---|---|
| 2018 | Hardy, T. S. E., De Sousa, S. M. C., & Norman, R. J. (2018). Obesity and reproduction. In M. J. Skinner (Ed.), Encyclopedia of Reproduction (2 ed., pp. 87-93). US: Academic Press. DOI Scopus1 |
| 2018 | Hardy, T. S. E., De Sousa, S. M. C., & Norman, R. J. (2018). Obesity and Reproduction. In Encyclopedia of Reproduction Volume 1 6 Second Edition (Vol. 4, pp. 87-93). DOI |
| 2015 | De Sousa, S., & Norman, R. J. (2015). A patient found to have Cushing syndrome. In N. S. Macklon, H. M. Fatemi, R. J. Norman, & P. Patrizio (Eds.), Case Studies in Assisted Reproduction: Common and Uncommon Presentations (pp. 50-52). Cambridge: Cambridge University Press. DOI |
| 2013 | Hardy, T., De Sousa, S., & Norman, R. J. (2013). Polycystic ovary syndrome: Prognosis and risk of comorbidity. In Novel Insights into the Pathophysiology and Treatment of Pcos (pp. 123-137). Future Medicine Ltd. DOI Scopus2 |
| Year | Citation |
|---|---|
| 2018 | De Sousa, S. M. C., McCormack, A. I., McGrath, S., & Torpy, D. J. (2018). Use of prolactin in inferior petrosal sinus sampling is misleading. In CLINICAL ENDOCRINOLOGY Vol. 89 (pp. 32). Perth, AUSTRALIA: WILEY. WoS1 |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Co-Supervisor | Improving safety and efficacy in endoscopic pituitary adenoma surgery | Doctor of Philosophy | Doctorate | Full Time | Mr Christopher Dillon Ovenden |
| 2025 | Principal Supervisor | Novel applications of molecular imaging and theranostics in endocrine neoplasia. | Doctor of Philosophy | Doctorate | Part Time | Mr James Michael McNeil |
| 2025 | Co-Supervisor | Improving safety and efficacy in endoscopic pituitary adenoma surgery | Doctor of Philosophy | Doctorate | Full Time | Mr Christopher Dillon Ovenden |
| 2025 | Principal Supervisor | Novel applications of molecular imaging and theranostics in endocrine neoplasia. | Doctor of Philosophy | Doctorate | Full Time | Mr James Michael McNeil |
| 2022 | Co-Supervisor | The Genetic Epidemiology of Hereditary Pancreatitis in Australia and its effects on patients of Total Pancreatectomy with Auto Islet Transplantation. | Doctor of Philosophy | Doctorate | Full Time | Mr Denghao Wu |
| 2022 | Co-Supervisor | The Genetic Epidemiology of Hereditary Pancreatitis in Australia and its effects on patients of Total Pancreatectomy with Auto Islet Transplantation. | Doctor of Philosophy | Doctorate | Full Time | Mr Denghao Wu |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2019 - ongoing | Co-Chair | ESA Early Career Researcher Committee | Endocrine Society of Australia | Australia |